mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.7 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
-0.06 |
0.7 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |